Insulin-like growth factor-1 (IGF-1) has a costimulatory effect on proliferation of committed progenitors derived from human umbilical cord CD34+ cells

被引:17
作者
Frostad, S
Bjerknes, R
Abrahamsen, JF
Olweus, J
Bruserud, O
机构
[1] Univ Bergen, Haukeland Hosp, Div Endocrinol, N-5020 Bergen, Norway
[2] Univ Bergen, Haukeland Hosp, Div Haematol, Dept Med B, N-5020 Bergen, Norway
[3] Univ Bergen, Haukeland Hosp, Dept Pediat, N-5020 Bergen, Norway
[4] Univ Bergen, Haukeland Hosp, Dept Pathol, Gade Inst, N-5020 Bergen, Norway
[5] Becton Dickinson Immunocytometry Syst, San Jose, CA 95131 USA
关键词
umbilical cord hematopoietic stem cells; insulin-like growth factor-1 (IGF-1); granulocyte colony stimulating factor;
D O I
10.1002/stem.160334
中图分类号
Q813 [细胞工程];
学科分类号
摘要
The effects of insulin-like growth factor-1 (IGF-1) on highly enriched human umbilical cord CD34(+) cells were investigated in vitro. CD34(+) cells were cultured in serum-free medium containing stem cell factor (SCF), GM-CSF, and interleukin-3 (IL-3), Culture of CD34(+) cells for one week in the presence of these cytokines resulted in a dose-dependent increase in total cell number. Addition of G-CSF together with SCF+IL-3+GM-CSF increased the proliferation of myelopoietic cells as determined by the number of cells expressing the myelomonocytic marker CD64 and the granulocytic marker CD15 without significantly altering the number of CD34(+) cells in the cultures. In the presence of G-CSF, IGF-1 induced a dose dependent increase in the total cell number and a moderate but significant increase in the percentages of CD15(+), CD64(+) cells with sustained CD34(+) cell proliferation. We conclude that IGF-1 can enhance the in vitro proliferation of committed progenitor cells derived from umbilical cord CD34(+) cells.
引用
收藏
页码:334 / 342
页数:9
相关论文
共 29 条
[1]  
ARON DC, 1992, BIOFACTORS, V3, P211
[2]  
BARNES R, 1992, BONE MARROW TRANSPL, P281
[3]  
BASERGA R, 1992, RECEPTOR, V2, P261
[4]  
BEATTY PG, 1993, BLOOD, V81, P249
[5]   Purification of CD34+ cells is essential for optimal ex vivo expansion of umbilical cord blood cells [J].
Briddell, RA ;
Kern, BP ;
Zilm, KL ;
Stoney, GB ;
McNiece, IK .
JOURNAL OF HEMATOTHERAPY, 1997, 6 (02) :145-150
[6]  
Cicognani A, 1998, BONE MARROW TRANSPL, V21, pS161
[7]   Is in vitro expansion of human cord blood cells clinically relevant? [J].
Denning-Kendall, PA ;
Nicol, A ;
Horsley, H ;
Donaldson, C ;
Bradley, B ;
Hows, JM .
BONE MARROW TRANSPLANTATION, 1998, 21 (03) :225-232
[8]  
Donaldson C, 1996, BONE MARROW TRANSPL, V18, P725
[9]  
Geffner M, 1997, ACTA PAEDIATR, V86, P76
[10]   SAFETY OF STRINGENT PROPHYLACTIC PLATELET TRANSFUSION POLICY FOR PATIENTS WITH ACUTE-LEUKEMIA [J].
GMUR, J ;
BURGER, J ;
SCHANZ, U ;
FEHR, J ;
SCHAFFNER, A .
LANCET, 1991, 338 (8777) :1223-1226